Log In
BCIQ
Print this Print this
 

RGX-321

  Manage Alerts
Collapse Summary General Information
Company RegenxBio Inc.
Description 
Molecular Target
Mechanism of Action 
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPreclinical
Standard IndicationRetinitis
Indication DetailsTreat X-linked retinitis pigmentosa
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today